5476 - 5500 of 8654 Results
Title
Year
- Evidence for an Additive Neurorestorative Effect of Simultaneously Administered CDNF and GDNF in Hemiparkinsonian Rats: Implications for Different Mechanism of Action2017OPENTitle: Evidence for an Additive Neurorestorative Effect of Simultaneously Administered CDNF and GDNF in Hemiparkinsonian Rats: Implications for Different Mechanism of ActionJournal Name: eneuroPublisher: Society for NeuroscienceVol: 4Issue #: 1Start Page: ENEURO.0117End Page: 16.2017Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1523/eneuro.0117-16.2017Best OA location URL: https://www.eneuro.org/content/eneuro/4/1/ENEURO.0117-16.2017.full.pdfCitation Count: 52
-
OPENTitle: The Systemic Synuclein Sampling Study: Toward a Biomarker for Parkinson’s DiseaseJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 11Issue #: 4Start Page: 359End Page: 368Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2217/bmm-2016-0366Best OA location URL: https://www.futuremedicine.com/doi/pdf/10.2217/bmm-2016-0366Citation Count: 52
- Reply to: ‘Letter to the Editor on “Sex Differences in Parkinson's Disease Phenotype and Caregiving Disparities”’2021RESTRICTEDTitle: Reply to: ‘Letter to the Editor on “Sex Differences in Parkinson's Disease Phenotype and Caregiving Disparities”’Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 2Start Page: 527End Page: 528Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28456Citation Count: 1
-
RESTRICTEDTitle: Functional ataxia in a specialized ataxia centerJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 120Issue #:Start Page: 106006End Page: 106006Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.106006Citation Count: 0
-
OPENTitle: Feasibility of repeat and bilateral submandibular gland needle biopsies in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 68Issue #:Start Page: 69End Page: 72Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.10.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9979781Citation Count: 17
- Identification of small molecule dimethyoxyphenyl piperazine inhibitors of alpha-synuclein fibril growth2025OPENTitle: Identification of small molecule dimethyoxyphenyl piperazine inhibitors of alpha-synuclein fibril growthJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41598-025-17658-yBest OA location URL: https://www.nature.com/articles/s41598-025-17658-y.pdfCitation Count: 0
- LRRK2 dynamics analysis identifies allosteric control of the crosstalk between its catalytic domains2022OPENTitle: LRRK2 dynamics analysis identifies allosteric control of the crosstalk between its catalytic domainsJournal Name: PLOS BiologyPublisher: Public Library of Science (PLoS)Vol: 20Issue #: 2Start Page: e3001427End Page: e3001427Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pbio.3001427Best OA location URL: https://doi.org/10.1371/journal.pbio.3001427Citation Count: 25
- DNA methylation changes associated with Parkinson’s disease progression: outcomes from the first longitudinal genome-wide methylation analysis in blood2019OPENTitle: DNA methylation changes associated with Parkinson’s disease progression: outcomes from the first longitudinal genome-wide methylation analysis in bloodJournal Name: EpigeneticsPublisher: Informa UK LimitedVol: 14Issue #: 4Start Page: 365End Page: 382Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/15592294.2019.1588682Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15592294.2019.1588682?needAccess=trueCitation Count: 78
- Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in mice2017OPENTitle: Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in miceJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.28377Best OA location URL: https://doi.org/10.7554/elife.28377Citation Count: 96
- 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction2018RESTRICTEDTitle: 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interactionJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 121Issue #:Start Page: 120End Page: 130Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.018Citation Count: 33
- LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodies2016RESTRICTEDTitle: LRRK2 levels and phosphorylation in Parkinson's disease brain and cases with restricted Lewy bodiesJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 3Start Page: 423End Page: 432Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26892Citation Count: 44
-
OPENTitle: At a crossroads: Revisiting mild cognitive impairment in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 4Start Page: 501End Page: 502Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27310Best OA location URL: https://escholarship.org/content/qt6ds4v3z7/qt6ds4v3z7.pdfCitation Count: 1
-
OPENTitle: The Future of GDNF in Parkinson's DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.593572Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2020.593572/pdfCitation Count: 43
-
OPENTitle: Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 12Issue #: 10Start Page: e0186508End Page: e0186508Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0186508Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0186508&type=printableCitation Count: 39
-
OPENTitle: TRIM28 regulates the nuclear accumulation and toxicity of both alpha-synuclein and tauJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 5Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.19809Best OA location URL: https://doi.org/10.7554/elife.19809Citation Count: 122
- General anaesthesia decreases the uniqueness of brain functional connectivity across individuals and species2025OPENTitle: General anaesthesia decreases the uniqueness of brain functional connectivity across individuals and speciesJournal Name: Nature Human BehaviourPublisher: Springer Science and Business Media LLCVol: 9Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41562-025-02121-9Best OA location URL: https://doi.org/10.1038/s41562-025-02121-9Citation Count: 2
-
OPENTitle: Inhibition of LRRK2 or Casein Kinase 1 Results in LRRK2 Protein DestabilizationJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 56Issue #: 8Start Page: 5273End Page: 5286Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s12035-018-1449-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s12035-018-1449-2.pdfCitation Count: 18
-
OPENTitle: Body-first versus brain-first biological subtyping of Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 10Start Page: 2871End Page: 2873Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa293Best OA location URL: https://academic.oup.com/brain/article-pdf/143/10/2871/35939469/awaa293.pdfCitation Count: 21
-
OPENTitle: Rapid 2D 23Na MRI of the calf using a denoising convolutional neural networkJournal Name: Magnetic Resonance ImagingPublisher: Elsevier BVVol: 110Issue #:Start Page: 184End Page: 194Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.mri.2024.04.027Best OA location URL: https://doi.org/10.1016/j.mri.2024.04.027Citation Count: 2
-
RESTRICTEDTitle: MicroRNAs as Molecular Biomarkers for Parkinson's Disease ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1793End Page: 1793Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28700Citation Count: 1
- GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor2012OPENTitle: GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitorJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 22Issue #: 17Start Page: 5625End Page: 5629Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2012.06.104Best OA location URL: http://doi.org/10.1016/j.bmcl.2012.06.104Citation Count: 149
- Identification of rare protein disulfide isomerase gene variants in amyotrophic lateral sclerosis patients2015OPENTitle: Identification of rare protein disulfide isomerase gene variants in amyotrophic lateral sclerosis patientsJournal Name: GenePublisher: Elsevier BVVol: 566Issue #: 2Start Page: 158End Page: 165Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.gene.2015.04.035Best OA location URL: https://repositorio.uchile.cl/handle/2250/133590Citation Count: 73
- Large-scale proteomics analysis of five brain regions from Parkinson’s disease patients with a GBA1 mutation2024OPENTitle: Large-scale proteomics analysis of five brain regions from Parkinson’s disease patients with a GBA1 mutationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00645-xBest OA location URL: https://www.nature.com/articles/s41531-024-00645-x.pdfCitation Count: 6
- Neurosurgeons perspective on the shift towards earlier use of deep brain stimulation for Parkinson disease2021OPENTitle: Neurosurgeons perspective on the shift towards earlier use of deep brain stimulation for Parkinson diseaseJournal Name: Interdisciplinary NeurosurgeryPublisher: Elsevier BVVol: 25Issue #:Start Page: 101224End Page: 101224Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.inat.2021.101224Best OA location URL: https://doi.org/10.1016/j.inat.2021.101224Citation Count: 2
-
OPENTitle: CLIPPERS: A Treatable Cause of Spastic AtaxiaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 2Start Page: 212End Page: 214Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12602Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12602Citation Count: 2